Sandy McDougall

Sandy McDougall has a diverse and extensive work experience spanning over several decades. They began their career in 1980 as a Corporate Finance Manager at EY before moving on to Tarmac in 1985, where they served as a Subsidiary Controller. From 1987 to 1991, McDougall worked at Compaq Computer Corporation as a Manufacturing Finance Manager. They then joined MURRAY JOHNSTONE LIMITED in 1991 as a Director and Group Financial Controller. McDougall served as CEO/CFO at PanTherix Ltd from 1999 to 2005, and then as Chief Financial Officer at Craneware plc from 2005 to 2008. From 2008 onwards, McDougall worked at Portfolio as a Portfolio CFO & Advisory. They joined Synpromics Ltd in 2016 as Chief Financial Officer until November 2021. Currently, McDougall serves as the Chief Financial Officer at Laverock Therapeutics, starting in July 2021.

Sandy McDougall's education history includes attending ICAS - The Professional Body of CAs, Hutchesons' Grammar School, and the University of Strathclyde. There is no specific information about the start and end years for any of these educational institutions. Sandy McDougall obtained a Bachelor of Business Administration (BA) degree from the University of Strathclyde, with a focus on Accountancy and Economics.